W
WAVEMAN · COMPANY
CDT · Cdt Equity Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

CDT

CDT Equity Inc.
PHARMA & BIOTECH · PHARMACEUTICAL PREPARATIONS · CIK 0001896212
ACTIVIST 13D☆ WATCH
INSIDER NET · 180D
-$2.9M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
8
13F, latest reported quarter
REVENUE GROWTH
-
XBRL, annual
NET MARGIN
-
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$2.9M over 180 days
-$2.9M over 90 days · -$2.9M of it by a 10%+ holder
below 72% of Pharma & Biotech
CONGRESS
no member of Congress has reported trading it
FUNDS
8 funds added or opened last quarter
below 89% of Pharma & Biotech
REVENUE
no revenue reported in any filing
MARGIN
no margin: this company reports no revenue to divide by
BUYBACKS
$106.0K repurchased, FY to 2025-12-31
below 95% of Pharma & Biotech
SHORT
2.3% of shares outstanding short · 1.0 days to cover · settled 2026-07-31
below 62% of Pharma & Biotech
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Taylor Mark Andrew disclosed a 5%+ stake (43.79%) in the last six months.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -99.7%
-99.7%12M
-100%-67%-33%+0%2025-092025-102025-122026-032026-052026-072026-09 2026-06-18 · Prospect Capital Securities Ltd sold $2.1M2026-06-18 · Prospect Capital Securities Ltd sold $830.6K2026-06-18 · Prospect Capital Securities Ltd sold $3.8K2026-06-18 · Prospect Capital Securities Ltd sold $3.5K2026-08-28 · Regan Andrew sold -2026-03-30 · Taylor Mark Andrew filed a 5%+ stake (43.79%)2026-03-30 · Prospect Capital Securities Ltd filed a 5%+ stake (31.12%)2026-03-30 · Prospect Finance Ltd filed a 5%+ stake (12.67%)
INSIDER SELL13D/G STAKE
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
An activist crossed the 5% line with declared intent.
The record shows a net $2.9M sold by insiders over 180 days, 8 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, CDT Equity Inc. insiders sold a net $2.9M of stock across 21 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
Regan Andrew
Chief Executive Officer
SELL
2026-08-28
290.0
-
Prospect Capital Securities Ltd
SELL
2026-06-18
5,000.0
$3.8K
Prospect Capital Securities Ltd
SELL
2026-06-18
1,464,711.0
$2.1M
Prospect Capital Securities Ltd
SELL
2026-06-18
593,289.0
$830.6K
Prospect Capital Securities Ltd
SELL
2026-06-18
5,000.0
$3.5K
21 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 16 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
BOOTHBAY FUND MANAGEMENT, LLC
250,000.0 sh
$140.0K
JANE STREET GROUP, LLC
61,190.0 sh
$34.3K
CITADEL ADVISORS LLC
32,295.0 sh
$18.1K
Polar Asset Management Partners Inc.
950,000.0 sh
$13.9K
Saba Capital Management, L.P.
765,000.0 sh
$12.5K
5%+ owners
13D = intent to influence · 13G = passive
Taylor Mark Andrew
ACTIVIST 13D · 2026-03-30
43.79%
Prospect Capital Securities Ltd
ACTIVIST 13D · 2026-03-30
31.12%
Prospect Finance Ltd
ACTIVIST 13D · 2026-03-30
12.67%
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Fidelity Extended Market Index Fund
$16.1K POSITION · AS OF 2026-02-28
0.0%
Fidelity Series Total Market Index Fund
$872 POSITION · AS OF 2026-02-28
0.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
OPERATING INCOME$-36.8M$-15.4M$-5.3M$-3.2M
NET INCOME$-39.2M$-17.8M$-535.0K$-4.9M
EPS (DILUTED)-1,177.89-61,598.62-8.92-0.13
OPERATING CASH FLOW$-15.6M$-9.7M$-7.7M$-2.3M
CASH$1.5M$554.0K$4.2M$345.8K
BUYBACKS$106.0K
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →